Dev Labtech Venture: ₹17.81 Cr Warrants Plan in 2026
Ask Iris
Board clears fund-raise proposal and capital hike
Dev Labtech Venture Limited has moved to increase its authorised share capital and raise funds through a preferential issuance route. The company disclosed that its board approved an increase in authorised capital to ₹31.00 crore. Alongside this, the board proposed the issuance of up to 1,37,00,000 convertible warrants. The warrants are proposed to be issued at ₹13 each, aggregating to ₹17.81 crore.
The proposals are structured as a preferential issue of convertible securities, which typically require shareholder approval. The company has, therefore, scheduled an Extraordinary General Meeting (EGM) to take the approvals forward. The disclosures were made in line with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, through intimation to BSE.
What the preferential warrant issue includes
As per the board outcome disclosures, Dev Labtech Venture approved a preferential issue of up to 1.37 crore convertible warrants. The issue price cited is ₹13 per warrant, taking the aggregate proposed mobilisation to ₹17.81 crore. The item is positioned as a capital-raising move, subject to shareholder consent.
Convertible warrants can ultimately translate into equity shares upon conversion, depending on the terms approved by shareholders and applicable regulations. The company’s announcement specifically refers to “equity shares or convertible securities,” reflecting the broader enabling language used in corporate approvals. The final execution remains linked to EGM approval and completion of procedural requirements.
EGM date, time, and e-voting cut-off
Dev Labtech Venture has scheduled its EGM for November 5, 2026 at 1:00 pm. The meeting will be held through Video Conferencing (VC), consistent with the company’s recent pattern of remote shareholder meetings. The company also fixed October 29, 2026 as the cut-off date for determining eligibility to vote by electronic means.
For the voting process, Mr. Ricky Kapadia has been appointed as Scrutinizer. NSDL has been engaged to provide the e-Voting platform. These steps were disclosed as part of the regulatory compliance communication around the board’s decisions.
How the stock price data was presented around the EGM
The data provided alongside the corporate action included last traded price (LTP) references around the EGM schedule. For the EGM record date of November 5, 2026, the LTP at announcement was stated as ₹22.09, while the LTP at record day was stated as ₹19.01. Separately, the company’s “current share price” was cited as ₹18 in the provided information.
Price points in such disclosures help investors contextualise the timing of corporate actions relative to the market. However, the corporate decision itself remains focused on approvals and process, rather than near-term price movements.
33rd AGM: outcomes and audit observations for FY26
Before the EGM-related disclosures, Dev Labtech Venture concluded its 33rd Annual General Meeting (AGM) on September 26, 2026 via video conferencing. The AGM concluded with all three proposed resolutions passing with 100% votes in favour, as per the information provided.
The meeting was reported to have seen no member queries. The auditors also reported no adverse observations for FY26. The company’s AGM process and outcome matter because they reflect the shareholder voting environment and the company’s ongoing compliance cadence ahead of another shareholder vote at the EGM.
AGM agenda also included a proposed land acquisition deal
The company had scheduled the AGM to seek shareholder approval for a material related-party transaction valued at up to ₹18.00 crore (excluding applicable taxes) for FY27. The transaction relates to the acquisition of land in Ankleshwar, Gujarat, intended for operational expansion.
The AGM agenda also included adoption of standalone and consolidated audited financial statements for FY26. Another agenda item was the reappointment of Mr. Jerambhai Lavjibhai Donda (DIN: 00484152) as a director liable to retire by rotation. The meeting and documentation were disclosed under Regulation 30 and Regulation 36(1)(b) of SEBI LODR.
Business profile: natural and lab-grown diamond focus
Dev Labtech Venture Limited is engaged in manufacturing, marketing, and sourcing of diamonds for use in jewellery, covering both natural and lab-grown categories. The company’s capabilities include processing diamonds across sizes, shapes, clarity, and colour specifications. The disclosures also note that the company uses Microwave plasma chemical vapor deposition (MPCVD) technology for lab-grown diamonds.
The company’s diamonds are stated to carry GIA and IGI certifications. It is also described as having pivoted to lab-grown diamonds in 2022 after nearly three decades in the traditional diamond trade. The firm was founded in 1993 and operates from a base inside the Surat Diamond Bourse, according to the provided background.
Key facts at a glance
Timeline: AGM to EGM sequence
The company’s corporate actions in FY26-27 have clustered around shareholder meetings conducted through VC. The 33rd AGM on September 26, 2026 concluded with unanimous approvals and no adverse audit observations for FY26, based on the information provided. Shortly after, the October 7, 2026 board meeting approved the authorised capital increase and proposed a preferential warrant issue.
The next milestone is the EGM on November 5, 2026, where shareholder approval is expected to be sought for the fund-raise related resolutions. The company also set an October 29, 2026 cut-off date to determine voting eligibility, establishing the procedural window for participation.
Market impact and what investors typically track
From an investor standpoint, the central near-term trigger is the EGM vote on November 5, 2026. The disclosed quantum is ₹17.81 crore through convertible warrants, which can be relevant in assessing the scale of fund-raising relative to the company’s operations. The authorised capital increase to ₹31.00 crore is a structural step that enables issuance capacity, including potential equity-linked instruments.
Investors also track process markers such as cut-off dates, e-voting arrangements, and scrutiny mechanisms, because these indicate how the shareholder approval process will be administered. The LTP references around the EGM record date were provided as part of the corporate action data, with ₹22.09 at announcement and ₹19.01 on record day, and an additional cited “current share price” of ₹18 in the provided information.
Analysis: why these approvals matter in the current context
The company’s recent disclosures place it in a phase where it is combining operational narrative with capital-market activity. Its stated focus on both natural and lab-grown diamonds, including MPCVD-based manufacturing and certified output (GIA and IGI), provides the business context in which it is seeking additional capital flexibility. The pivot to lab-grown diamonds in 2022, as described, also frames the capital-raising proposal as part of a broader strategic direction.
At the governance level, the sequence of a unanimously concluded AGM followed by an EGM for capital-related approvals indicates that the company is using shareholder meetings to clear multiple enabling resolutions. The related-party transaction approval sought at the AGM, involving up to ₹18.00 crore for land acquisition in Ankleshwar for expansion, adds a second track of corporate decision-making that shareholders have been asked to evaluate.
Conclusion
Dev Labtech Venture has approved an authorised capital increase to ₹31.00 crore and proposed a ₹17.81 crore preferential issue of up to 1.37 crore convertible warrants at ₹13 each, subject to shareholder approval. The EGM is scheduled for November 5, 2026 at 1:00 pm via VC, with October 29, 2026 set as the e-voting cut-off date and NSDL engaged for the voting process.
The next confirmed step is the shareholder vote at the EGM, which will determine whether the company can proceed with the proposed issuance under the disclosed terms.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker
